Concepedia

Shazreh Bukhari

SB

Statistics

Publications

10

Citations

293

H-Index

10

Active since

1970

Affiliations

University of Toronto(Current)

Hotchkiss Brain Institute

Canada's Michael Smith Genome Sciences Centre

University of Calgary

Hospital for Sick Children

Shazreh Bukhari is an author at University of Toronto specializing in pharmacology, molecular oncology, and medicine.

Publications per year

1970–2022

10

Publications

10

Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia

Krimo Toutah, Nabanita Nawar, Sanna Timonen et al. · Journal of Medicinal Chemistry · 2021 · 46 citations · Full text

, , +16

PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia

Justyna M. Gawel, Andrew E. Shouksmith, Yasir S. Raouf et al. · European Journal of Medicinal Chemistry · 2020 · 41 citations · Full text

, , +8

The gentamicin antibiotics. Part III. The gross structures of the gentamicin C components

David J. Copper, P. Daniels, Milton D. Yudis et al. · Journal of the Chemical Society C Organic · 1971 · 35 citations

, , +9

ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts

Alice Yuan, Christian B. Ricks, Alexandra Böhm et al. · PLoS ONE · 2018 · 34 citations · Full text

, , +14

Discovery of HDAC6-Selective Inhibitor NN-390 with <i>in Vitro</i> Efficacy in Group 3 Medulloblastoma

Nabanita Nawar, Shazreh Bukhari, Ashley Adile et al. · Journal of Medicinal Chemistry · 2022 · 31 citations · Full text

, , +15

1–5 of 10